Product Image

Omega JYM

JYM Supplement Science
4.8
★ ★ ★ ★ ★
(451 ratings)
EPA (Eicosapentaenoic Acid) 750 mg
Fish Oil 2600 mg
DHA 750 mg
Docosapentaenoic acid 150 mg
Product Image
Score81
A concentrated EPA-and-DHA serving is clearly disclosed, but missing form and testing details limit confidence in oil quality.
How scoring works
Quantity:120 Softgel(s) • (60 servings)
Goals:
Cardiovascular Support
Heart Health
Anti-Inflammatory Support
Mental Focus

Score 81

A concentrated EPA-and-DHA serving is clearly disclosed, but missing form and testing details limit confidence in oil quality.
How scoring works
$29.99($0.49 per serving)
Nutrition Faktory
$ 29.99
iHerb
$ 34.99
Report prices

Analysis

The formula supplies 750 mg EPA and 750 mg DHA per serving, plus 150 mg DPA, giving a substantial omega-3 dose. Both key omega-3s are quantified, so the active amount is easy to assess.

The concentrated serving fits adults seeking meaningful omega-3 intake for heart health and cardiovascular support. DPA adds another 150 mg alongside EPA and DHA. The amount of active omega-3 provided per serving also compares favorably with the product cost.

The label does not identify the omega-3 molecular form or provide independent purity and oxidation test results, so important quality details remain uncertain. The softgel(s) format may be convenient for routine use, but the disclosed facts do not establish freshness or contaminant control.

Who is it for
  • Adults seeking a concentrated daily fish-oil serving
  • People focused on cardiovascular or inflammatory support
Best for
  • Heart Health
  • Cardiovascular Support
  • Anti-Inflammatory Support

Pros

  • EPA and DHA are listed separately at 750 mg and 750 mg per serving
  • Concentrated active omega-3 amount per serving
  • Includes 150 mg of DPA in addition to EPA and DHA

Cons

  • Omega-3 molecular form is not identified
  • Independent purity and oxidation testing is not provided
  • Fish source or processing details are limited

Warnings

  • Avoid if you have a fish allergy because the active oil is fish-derived.
  • The 1650 mg combined EPA, DHA, and DPA serving may add to bleeding risk with anticoagulant or antiplatelet medicines; discuss this dose with the prescribing clinician.
  • Fish oil can cause burping or stomach upset; taking it with a meal may improve tolerance.

Nutrient quality

85 Highest impact

A substantial and clearly quantified EPA, DHA, and DPA profile provides strong dose depth. Missing molecular-form, sourcing, oxidation, purification, and testing details limit quality confidence.

.

Ingredient transparency

81 Highest impact

Active amounts are individually disclosed, and no proprietary blend hides the supplied doses. Complete use directions, excipients, and some source or quality details remain unavailable.

.

Customer satisfaction

68 High impact

Supplied aggregate data indicate very strong satisfaction with a moderate response base. Specific comments are absent, so recurring complaints and purpose-specific experiences cannot be verified.

.

Value for money

91 Highest impact

A substantial three-fatty-acid profile provides strong practical value. Sparse sourcing and quality-control detail remain the main limitation.

.
Report analysis

Goals

Cardiovascular Support
Cardiovascular Support
Impact
Highest effect
A+ Goal FitA+ Strength of SupportB CoverageA+ Formula Quality
Fish Oil · 2600 mg

EPA and DHA at 750 mg each provide direct, clearly quantified omega-3 support for cardiovascular health. Human evidence is robust for triglyceride management and broader cardiometabolic effects of EPA and DHA.

The additional DPA broadens the marine-fatty-acid profile without diluting the core dose. People using anticoagulant or antiplatelet medicines should review this concentrated fish oil with a clinician because omega-3s can add to bleeding risk.

Study evidence
Fish Oil Supportive 185 studies
Heart Health
Heart Health
Impact
Highest effect
A+ Goal FitA+ Strength of SupportB CoverageA+ Formula Quality
EPA (Eicosapentaenoic Acid) · 750 mg

EPA and DHA at 750 mg each provide direct, clearly quantified omega-3 support for cardiovascular health. Human evidence is robust for triglyceride management and broader cardiometabolic effects of EPA and DHA.

The additional DPA broadens the marine-fatty-acid profile without diluting the core dose. People using anticoagulant or antiplatelet medicines should review this concentrated fish oil with a clinician because omega-3s can add to bleeding risk.

Study evidence
Anti-Inflammatory Support
Anti-Inflammatory Support
Impact
Highest effect
A+ Goal FitB+ Strength of SupportB+ CoverageA+ Formula Quality
Fish Oil · 2600 mg

EPA, DHA, and DPA provide strong support for inflammatory resolution and cell-membrane balance. The combined EPA and DHA amount reaches an effective daily range with clear individual disclosure.

The fish source, molecular form, purification, independent testing, and oxidation protection are not stated. The 1.5 g EPA and DHA amount may add to bleeding risk for people using anticoagulant or antiplatelet medicines.

Mental Focus
Mental Focus
Impact
High effect
D+ Goal FitB Strength of SupportC CoverageA Formula Quality

The concentrated EPA and DHA amounts provide substantial omega-three support, but their relevance to day-to-day mental focus is indirect. Evidence is more consistent for general brain structure, mood, and inflammatory balance than for immediate attention gains.

Both major fatty acids are clearly disclosed, while the molecular form, oxidation protection, and independent contaminant testing are not supplied. The balanced formula offers depth in one long-term nutritional pathway without acute alertness or neurotransmitter support.

Study evidence

Ingredients

IngredientAmount per serving
Calories
25 Calorie(s)
Total Fat
2.5 Gram(s)
Total Fish Oil
2600 mg
Eicosapentaenoic Acid
750 mg
Docosahexaenoic Acid
750 mg
Docosapentaenoic Acid
150 mg
Adults 18–50 Women
Report overview
EPA (Eicosapentaenoic Acid) · 750 mg OverallScore53
D- Active Ingredient Quality & BioavailabilityD+ Dose, Safety & Label TransparencyB+ Value

The oil delivers a strong EPA amount, but the molecular form and antioxidant protection are not stated. Equal EPA and DHA make it a balanced omega-three formula rather than an EPA-centered option. Its EPA cost is efficient, while the absence of contaminant-testing evidence limits transparency.

View ingredientView products
Fish Oil · 2600 mg OverallScore51
F Active Ingredient Quality & BioavailabilityC+ Dose, Safety & Label TransparencyA+ Value

The combined EPA and DHA amount is effective and individually disclosed, with a standard oil concentration. Cost per active amount is excellent. The unspecified molecular form, fish source, purification, independent testing, and oxidation protection leave quality assurance incomplete.

View ingredientView products
DHA · 750 mg OverallScore43
F Active Ingredient Quality & BioavailabilityD Dose, Safety & Label TransparencyB+ Value
The DHA dose is high and the oil also supplies substantial EPA. The combined EPA and DHA concentration is moderate rather than highly refined, while form, antioxidant protection, fish species, and testing are not disclosed. Cost per gram of DHA remains favorable for the active amount delivered.
View ingredientView products
Loading alternative details
87 Performance

Omega-3

Solgar
<p>A more concentrated serving provides 1,008 mg EPA and 756 mg DHA, giving greater omega-3 depth than the original's 750 mg EPA and 750 mg DHA. Mixed tocopherols aid oxidation control, but molecular form, fish source, purification method, and independent testing remain unclear.</p>
85 Performance

Omega-3 Triglyceride Fish Oil 1100 mg

NATURELO Premium Supplements
<p>A molecularly distilled triglyceride fish oil with 729 mg EPA and 275 mg DHA provides more specific form and processing detail than the original. Molecular distillation adds some purity assurance, while missing independent testing, fish species, and antioxidant protection leave smaller quality gaps.</p>
83 Performance

Super Omega-3

Life Extension
<p>A clearly quantified serving of 700 mg EPA and 500 mg DHA offers a more focused EPA-and-DHA profile than the original. The large package provides strong active value, though the four-softgel serving is less convenient and oil-quality documentation remains incomplete.</p>
86 Budget

Omega-3 Triglyceride Fish Oil 1100 mg

NATURELO Premium Supplements
<p>A lower recurring cost provides 729 mg EPA and 275 mg DHA, compared with the original's 750 mg EPA and 750 mg DHA. Molecular distillation adds some purity assurance, while missing independent testing, fish species, and antioxidant protection leave smaller quality gaps.</p>
86 Budget

Purified & Clear Omega 3 Fish Oil 1000 mg

Doctor's Best
<p>A lower recurring cost provides 800 mg EPA and 400 mg DHA, compared with the original's 750 mg EPA and 750 mg DHA. The ethyl-ester form is less readily absorbed than triglyceride oil, and oxidation protection plus independent purity testing are not supplied.</p>
84 Budget

Mega EPA/DHA

Life Extension
<p>A lower recurring cost provides 720 mg EPA and 480 mg DHA, compared with the original's 750 mg EPA and 750 mg DHA. The oil molecular form, fish species, purification, and independent testing remain undisclosed.</p>
84 Value

Fish Oil 1400 mg

Nature's Bounty
<p>A favorable balance of active dose and recurring cost provides 647 mg EPA and 253 mg DHA with better practical value than the original. The ethyl-ester form is less readily absorbed, while fish source, antioxidant protection, and independent purity testing are not stated.</p>
84 Value

Alaska Wild Fish Oil Mega Omega-3

21st Century
<p>A favorable balance of active dose and recurring cost provides 965 mg EPA and 385 mg DHA with better practical value than the original. Molecular form, antioxidant protection, fish species, and independent purity testing are not disclosed.</p>
83 Value

Super Omega-3

Life Extension
<p>A favorable balance of active dose and recurring cost provides 700 mg EPA and 500 mg DHA with better practical value than the original. The larger package improves active value, but fish species, molecular form, purification, and independent testing are not provided.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
    Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Saito Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Japan EPA lipid intervention study (JELIS) Investigators · Lancet (London, England) · 2007
    Randomized trial18,645 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  2. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G · European journal of preventive cardiology · 2024
    Meta-analysis134,144 participants18 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  3. Meta-analysis Comparing Combined Use of Eicosapentaenoic Acid and Statin to Statin Alone.
    Doshi R; Kumar A; Thakkar S; Shariff M; Adalja D; Doshi A; Taha M; Gupta R; Desai R; Shah J; Gullapalli N · The American journal of cardiology · 2020
    Meta-analysis27,415 participants5 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  4. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
    Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; JELIS Investigators, Japan · Atherosclerosis · 2008
    Randomized trial14,981 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  5. Eicosapentaenoic Acid combined with optimal statin therapy improves endothelial dysfunction in patients with coronary artery disease.
    Toyama K; Nishioka T; Isshiki A; Ando T; Inoue Y; Kirimura M; Kamiyama T; Sasaki O; Ito H; Maruyama Y; Yoshimoto N · Cardiovascular drugs and therapy · 2014
    Randomized trial80 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  6. Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome.
    Satoh N; Shimatsu A; Kotani K; Himeno A; Majima T; Yamada K; Suganami T; Ogawa Y · Hypertension research : official journal of the Japanese Society of Hypertension · 2010
    Randomized trial92 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  7. The Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Cardiometabolic Risk Factors: A Systematic Review.
    Innes JK; Calder PC · International journal of molecular sciences · 2018
    Systematic review527 participants6 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  8. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids.
    Grimsgaard S; Bonaa KH; Hansen JB; Nordøy A · The American journal of clinical nutrition · 1997
    Randomized trial234 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  9. Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: a meta-analysis of randomized controlled trials.
    Hidayat K; Yang J; Zhang Z; Chen GC; Qin LQ; Eggersdorfer M; Zhang W · European journal of clinical nutrition · 2019
    Meta-analysis3,000 participants51 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  10. Long-Chain Polyunsaturated Fatty Acids Are Associated with Blood Pressure and Hypertension over 10-Years in Black South African Adults Undergoing Nutritional Transition.
    Zec MM; Schutte AE; Ricci C; Baumgartner J; Kruger IM; Smuts CM · Foods (Basel, Switzerland) · 2020
    Cohort study300 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  11. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE · Journal of the American Heart Association · 2020
    Meta-analysis127,477 participants13 studies pooledCardiovascular Support forFish Oil
  12. Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
    Lu J; Liu R; Ren H; Wang S; Hu C; Shi Z; Li M; Liu W; Wan Q; Su Q; Li Q; Zheng H; Qu S; Yang F; Ji H; Lin H; Qi H; Wu X; Wu K; Chen Y; Xu Y; Xu M; Wang T; Zheng J; Ning G; Zheng R; Bi Y; Zhong H; Wang W · Med (New York, N.Y.) · 2025
    Randomized trial309 participantsCardiovascular Support forFish Oil
  13. A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
    Campbell F; Dickinson HO; Critchley JA; Ford GA; Bradburn M · European journal of preventive cardiology · 2013
    Meta-analysis1,524 participants17 studies pooledCardiovascular Support forFish Oil
  14. Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
    Zeng Q; Dong SY; Liu YP; Fu J; Shuai P; Zhao ZM; Li TX · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2017
    Randomized trial422 participantsCardiovascular Support forFish Oil
  15. Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Sekikawa A; Cui C; Sugiyama D; Fabio A; Harris WS; Zhang X · Nutrients · 2020
    Meta-analysis6 studies pooledCardiovascular Support forFish Oil
  16. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
    Matsuzaki M; Yokoyama M; Saito Y; Origasa H; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Matsuzawa Y; JELIS Investigators · Circulation journal : official journal of the Japanese Circulation Society · 2009
    Randomized trialHeart Health forEPA (Eicosapentaenoic Acid)
  17. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology · Circulation · 2020
    OtherHeart Health forEPA (Eicosapentaenoic Acid)
  18. The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis.
    Suh SW; Lim E; Burm SY; Lee H; Bae JB; Han JW; Kim KW · BMC medicine · 2024
    Meta-analysis9,660 participants24 studies pooledMental Focus forEPA (Eicosapentaenoic Acid)
  19. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD.
    Gustafsson PA; Birberg-Thornberg U; Duchén K; Landgren M; Malmberg K; Pelling H; Strandvik B; Karlsson T · Acta paediatrica (Oslo, Norway : 1992) · 2011
    Randomized trial92 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  20. Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)-Should They Be Mandatory Supplements in Pregnancy?
    Amza M; Haj Hamoud B; Sima RM; Dinu MD; Gorecki GP; Popescu M; Gică N; Poenaru MO; Pleș L · Biomedicines · 2024
    Narrative reviewMental Focus forEPA (Eicosapentaenoic Acid)
  21. Supplementation with oil rich in eicosapentaenoic acid, but not in docosahexaenoic acid, improves global cognitive function in healthy, young adults: results from randomized controlled trials.
    Patan MJ; Kennedy DO; Husberg C; Hustvedt SO; Calder PC; Khan J; Forster J; Jackson PA · The American journal of clinical nutrition · 2021
    Randomized trial310 participantsMental Focus forEPA (Eicosapentaenoic Acid)